 The first-generation fluoroquinolone agents, such as flumequine, had poor distribution into the body tissues and limited activity.As such they were used mainly for treatment of urinary tract infections.Flumequine (benzo quinolizine) was first patented in 1973, (German Patent) by Rikker Labs.